Showing
1 - 4
results of
4
for search '
Zeidan A
'
Skip to content
Home
High Impact Articles
Search Options
UiTM Open Access
Search by UiTM Scopus
Advanced Search
Search by Category
Discovery Service
Sources
Jawi Collection
UiTM Journals
List UiTM Journal in IR
Statistic
About
Open Access
Creative Commons Licenses
COKI | Malaysia Open Access
Report Technical
User Guide
Contact Us
Search Tips
FAQs
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Author
Zeidan A
Showing
1 - 4
results of
4
for search '
Zeidan A
'
, query time: 0.05s
Refine Results
Sort
Relevance
Date Descending
Date Ascending
Call Number
Author
Title
1
Turbulent Shear Flow Recovery Behind Obstacles on Smooth and Rough Surfaces
by
Zeidan
,
A
.
Published 1980
Get full text
2
Identifying the essential nutritional requirements of the probiotic bacteria Bifidobacterium animalis and Bifidobacterium longum through genome-scale modeling
by
Franzén, C.J
,
Gaspar, P.
,
Neves, A.R
,
Schöpping, M.
,
Zeidan
,
A
.A
Published 2021
Call Number:
Loading...
Located:
Loading...
View Fulltext in Publisher
Article
3
Cost-effectiveness of gilteritinib for relapsed/ refractory FLT3mut+ acute myeloid leukemia
by
Garnham, A.
,
Pandya, B.J
,
Qi, C.Z
,
Shah, M.V
,
Yang, H.
,
Zeidan
,
A
.M
Published 2021
Call Number:
Loading...
Located:
Loading...
View Fulltext in Publisher
Article
4
BCL-2 Inhibitor Venetoclax Induces Autophagy-Associated Cell Death, Cell Cycle Arrest, and Apoptosis in Human Breast Cancer Cells
by
Alhoshani A
,
Alatawi FO
,
Al-Anazi FE
,
Attafi IM
,
Zeidan
A
,
Agouni A
,
El Gamal HM
,
Shamoon LS
,
Khalaf S
,
Korashy HM
Published 2020-12-01
Get full text
Article
Search Tools:
Get RSS Feed
—
Email this Search
Related Subjects
genetics
Aniline Compounds
Article
Bacteria
Bifidobacterium animalis
Bifidobacterium longum
CD135 antigen
Cost-Benefit Analysis
FLT3 protein, human
Humans
Leukemia, Myeloid, Acute
Nutritional Requirements
Probiotics
Pyrazines
Quality-Adjusted Life Years
Recurrence
Survival Analysis
United States
Willingness To Pay
acute myeloid leukemia
adult
adverse event
aged
aniline derivative
azacitidine
bacterium
controlled study
cost benefit analysis
cost effectiveness analysis
cytarabine
Loading...